Aptose Biosciences' leukemia drug shows early promise
Aptose Biosciences (NASDAQ:APTO;TSX:APS), a clinical-stage oncology stock, achieved positive safety and response results from ...
AI-driven genetic analysis uncovers insights for personalized cancer treatment
A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence ...
manilatimes7h
Aptose's Frontline Triple Drug Therapy with Tuspetinib Achieves Notable Responses in Newly Diagnosed AML Patients in the Phase 1/2 TUSCANY Trial
In January 2025, Aptose announced the initiation of the TUSCANY trial and dosing in the first cohort of newly-diagnosed AML ...
Scientists Uncover Cancer’s Earliest Warning Signs – Before You’re Even Born
Van Andel Institute researchers discovered that cancer risk may be determined before birth due to distinct epigenetic states ...